CTFFR and Prediction of Non-Significant CAD Lesions
Evaluation of the Ability of CTFFR to Determine Non-significant Lesions of Coronary Disease Based on MACE in One-year Follow-up of Patients (Seeing Beyond the Stenosis: CTFFR and MACE in a One-Year Follow-Up)
Shiraz University of Medical Sciences
250 participants
Jan 1, 2024
INTERVENTIONAL
Conditions
Summary
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE
Eligibility
Inclusion Criteria1
- Patients were enrolled if they had at least one intermediate coronary lesion (classified as 50-70% diameter stenosis on visual judgment) on CCTA and then underwent FFR testing
Exclusion Criteria5
- Patients having past coronary artery bypass graft surgery (CABG)
- previous PCI in the target vascular
- significant renal impairment define with eGFR < 30 mL/min/1.73 m²
- contrast allergy
- poor image quality that prevented appropriate CCTA or CT-FFR analysis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Fractional flow reserve derived from CT angiography from lesion between 50-70%
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06979427